Paclitaxel-eluting balloon dilation of biliary anastomotic stricture after liver transplantation

AIM:To investigate the safety and effectiveness of endoscopic therapy with a paclitaxel-eluting balloon(PEB) for biliary anastomotic stricture(AS) after liver transplantation(LT).METHODS:This prospective pilot study enrolled 13 consecutive eligible patients treated for symptomatic AS after LT at the...

Full description

Saved in:
Bibliographic Details
Published in:World journal of gastroenterology : WJG Vol. 21; no. 3; pp. 977 - 981
Main Authors: Hüsing, Anna, Reinecke, Holger, Cicinnati, Vito R, Beckebaum, Susanne, Wilms, Christian, Schmidt, Hartmut H, Kabar, Iyad
Format: Journal Article
Language:English
Published: United States Baishideng Publishing Group Inc 21-01-2015
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:AIM:To investigate the safety and effectiveness of endoscopic therapy with a paclitaxel-eluting balloon(PEB) for biliary anastomotic stricture(AS) after liver transplantation(LT).METHODS:This prospective pilot study enrolled 13 consecutive eligible patients treated for symptomatic AS after LT at the University Hospital of Münster between January 2011 and March 2014.The patients were treated by endoscopic therapy with a PEB and followed up every 8 wk by endoscopic retrograde cholangiopancreatography(ERCP).In cases of re-stenosis,further balloon dilation with a PEB was performed.Follow-up was continued until 24 mo after the last intervention.RESULTS:Initial technical feasibility,defined as successful balloon dilation with a PEB during the initial ERCP procedure,was achieved in 100% of cases.Long-term clinical success(LTCS),defined as no need for further endoscopic intervention for at least 24 mo,was achieved in 12 of the 13 patients(92.3%).The mean number of endoscopic interventions required to achieve LTCS was only 1.7 ± 1.1.Treatment failure,defined as the need for definitive alternative treatment,occurred in only one patient,who developed recurrent stenosis with increasing bile duct dilatation that required stent placement.CONCLUSION:Endoscopic therapy with a PEB is very effective for the treatment of AS after LT,and seems to significantly shorten the overall duration of endoscopic treatment by reducing the number of interventions needed to achieve LTCS.
Bibliography:Anna Hüsing;Holger Reinecke;Vito R Cicinnati;Susanne Beckebaum;Christian Wilms;Hartmut H Schmidt;Iyad Kabar;Department of Transplant Medicine,University Hospital Münster,48149 Münster,Germany;Division of Angiology,Department of Cardiology and Angiology,University Hospital Münster,48149 Münster,Germany
Liver transplantation;Anastomotic stricture;Endosc
AIM:To investigate the safety and effectiveness of endoscopic therapy with a paclitaxel-eluting balloon(PEB) for biliary anastomotic stricture(AS) after liver transplantation(LT).METHODS:This prospective pilot study enrolled 13 consecutive eligible patients treated for symptomatic AS after LT at the University Hospital of Münster between January 2011 and March 2014.The patients were treated by endoscopic therapy with a PEB and followed up every 8 wk by endoscopic retrograde cholangiopancreatography(ERCP).In cases of re-stenosis,further balloon dilation with a PEB was performed.Follow-up was continued until 24 mo after the last intervention.RESULTS:Initial technical feasibility,defined as successful balloon dilation with a PEB during the initial ERCP procedure,was achieved in 100% of cases.Long-term clinical success(LTCS),defined as no need for further endoscopic intervention for at least 24 mo,was achieved in 12 of the 13 patients(92.3%).The mean number of endoscopic interventions required to achieve LTCS was only 1.7 ± 1.1.Treatment failure,defined as the need for definitive alternative treatment,occurred in only one patient,who developed recurrent stenosis with increasing bile duct dilatation that required stent placement.CONCLUSION:Endoscopic therapy with a PEB is very effective for the treatment of AS after LT,and seems to significantly shorten the overall duration of endoscopic treatment by reducing the number of interventions needed to achieve LTCS.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Correspondence to: Iyad Kabar, MD, Department of Transplant Medicine, University Hospital Münster, Albert-Schweitzer-Campus 1, Gebäude A14, 48149 Münster, Germany. iyad.kabar@ukmuenster.de
Author contributions: Hüsing A, Reinecke H, Schmidt HH and Kabar I designed the study; Kabar I, Wilms C and Hüsing A performed the study; Hüsing A, Cicinnati VR, Wilms C, Beckebaum S and Kabar I collected the patient data; Hüsing A, Beckebaum S, Cicinnati VR, Reinecke H and Kabar I analyzed the data; Kabar I, Hüsing A, Cicinnati VR and Schmidt HH wrote the paper.
Telephone: +49-251-8344957 Fax: +49-251-8357771
ISSN:1007-9327
2219-2840
DOI:10.3748/wjg.v21.i3.977